Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShawbrook Group Regulatory News (SHAW)

Share Price Information for Shawbrook Group (SHAW)

Share Price is delayed by 15 minutes
Get Live Data
307.50    1.50 (0.49%)
Bid:
305.50
Ask:
308.00
Spread: 2.50 (0.818%)
Market Cap: £1.60b
SHAW Live PriceLast checked at - London Stock Exchange

Intraday Shawbrook Group Share Chart

Form 8 (OPD)

5 May 2017 16:56

RNS Number : 3857E
Shawbrook Group PLC
05 May 2017
 

FORM 8 (OPD)

Amendment to Section 3(b), Performance Share Plan 2015

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Shawbrook Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Shawbrook Group plc

(d) Is the discloser the offeror or the offeree?

Offeree

(e) Date position held:

The latest practicable date prior to the disclosure

9 March 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

1p ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

None

N/A

None

N/A

(2) Cash-settled derivatives:

 

None

N/A

None

N/A

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

None

N/A

None

N/A

 

TOTAL:

None

N/A

None

N/A

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

3 (a) Interests of directors of Shawbrook Group plc in Shawbrook Group plc's 1p ordinary shares

 

Director

Number of 1p ordinary shares

Percentage of total issued share capital (rounded to 3 decimal places)

Stephen Pateman

286,697

0.114

Dylan Minto

325,2581

0.129

Stephen Johnson

2,713,538

1.083

Robin Ashton

29,932

0.012

 

1 Interest is comprised of 270,258 1p ordinary shares, the registered holder of which is IG Markets Limited, and 55,000 1p ordinary shares, the registered holder of which is Interactive Investors. Both holdings are ultimately owned and controlled by Dylan Minto.

 

3 (b) Interests in Shawbrook Group plc's 1p ordinary shares held by directors pursuant to Shawbrook Group plc's share plans and incentive schemes

 

Deferred Share Bonus Plan

 

Director

Number of ordinary shares awarded

Date of grant

Vesting date

Exercise price per share

Stephen Pateman

114,116

8 March 2017

Vesting in equal tranches on 8 March 2018, 8 March 2019 and 8 March 2020

Nil

Dylan Minto

44,205

8 March 2017

Vesting in equal tranches on 8 March 2018, 8 March 2019 and 8 March 2020

Nil

Stephen Johnson

46,240

8 March 2017

Vesting in equal tranches on 8 March 2018, 8 March 2019 and 8 March 2020

Nil

38,377

9 March 2016

Vesting in equal tranches on 9 March 2017, 9 March 2018 and 9 March 2019

Nil

 

Performance Share Plan 2017

 

Director

Maximum number of ordinary shares awarded

Date of grant

Vesting date (subject to performance conditions)

Exercise price per share

Stephen Pateman

197,347

8 March 2017

8 March 2020

Nil

Dylan Minto

105,778

8 March 2017

8 March 2020

Nil

Stephen Johnson

82,096

8 March 2017

8 March 2020

Nil

 

Performance Share Plan 2016

 

Director

Maximum number of ordinary shares awarded

Date of grant

Vesting date (subject to performance conditions)

Exercise price per share

Stephen Pateman

204,135

9 March 2016

9 March 2019

Nil

Dylan Minto

39,194

9 March 2016

9 March 2019

Nil

Stephen Johnson

84,920

9 March 2016

9 March 2019

Nil

 

Performance Share Plan 2015

 

Director

Maximum number of ordinary shares awarded

Date of grant

Vesting date (subject to performance conditions)

Exercise price per share

Dylan Minto

46,160

27 August 2015

2 April 2018

Nil

 

Save As You Earn (SAYE)

 

Director

Amount saved (as at Date of Disclosure)

Number of ordinary shares purchasable based on exercise price and amount saved (as at Date of Disclosure)

Date of grant

Vesting date

Exercise price per share

Dylan Minto

£2,000

1,070

N/A

1 December 2019

£1.868

 

3 (c) Interests in Shawbrook Group plc's 1p ordinary shares held by directors pursuant to SOF 4 Award granted by SOF General Partner (Guernsey) Limited, acting in its capacity as general partner and manager of the Special Opportunities Fund (Guernsey) LP

 

Director

Number of ordinary shares awarded

Date of grant

Vesting date

Exercise price per share

Stephen Pateman

82,044

31 December 2015 (with effect from 1 January 2016)

18 February 2018

Nil

 

 

3 (d) Interests of close relatives of directors of Shawbrook Group plc in Shawbrook Group plc's 1p ordinary shares

 

Close relative

Director to whom close relative is connected

Relationship of close relative to director

Number of 1p ordinary shares

Percentage of total issued share capital (rounded to 3 decimal places)

Jasna Ashton

Robin Ashton

Spouse

566,761

0.226

 

 

3 (e) Interests of connected advisors in Shawbrook Group plc's 1p ordinary shares

 

Adviser

Number of 1p ordinary shares

Percentage of total issued share capital

Goldman Sachs International

None

N/A

Merrill Lynch International ("BofA Merrill Lynch")

None

N/A

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 May 2017

Contact name:

Daniel Rushbrook

Telephone number:

+44 (0)1277 358184

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEUVVVRBOAVRAR
Date   Source Headline
3rd Mar 20167:00 amRNSResults for the year ended 31 December 2015
19th Feb 201610:17 amRNSDirector/PDMR Shareholding
15th Feb 20168:13 amRNSNotice of Results
29th Jan 20163:29 pmRNSSale of shares to cover tax liabilities on vesting
4th Jan 20169:41 amRNSTotal Voting Rights and Share Capital
4th Jan 20169:33 amRNSGrant of Awards
8th Dec 20157:00 amRNSAdditional Listing
4th Dec 201512:06 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
3rd Dec 20154:14 pmRNSHugh Fitzpatrick LTIP award
1st Dec 20152:42 pmRNSAppointment of Non-Executive Director
13th Nov 20152:42 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARESi
12th Nov 20157:29 amRNSCompletion of Placing of Shares
5th Nov 20152:18 pmRNSAppointment of Non-Executive Director
5th Nov 20157:00 amRNSInterim Management Statement - Q3 2015
28th Oct 20154:58 pmRNSShawbrook 10NC5 T2 Post-Stabilisation Notice
26th Oct 20156:05 pmRNSPublication of Prospectus
21st Oct 201512:58 pmRNSIssue of Debt
21st Oct 201510:04 amRNSShawbrook 10NC5 T2 Pre-Stabilisation Notice
2nd Oct 20153:00 pmRNSOPTIONS AWARDED UNDER SHAWBROOK GROUP SAYE PLAN
2nd Oct 20159:00 amRNSAppointment of Chief Executive Officer
27th Aug 20153:27 pmRNSNotification of Transactions of PDMRs
25th Aug 20157:00 amRNSDirectorate Change
31st Jul 20157:00 amRNSAppointment of Joint Corporate Brokers
28th Jul 20157:00 amRNSHalf year results for the 6 months ended 30/06/15
8th Jul 20157:00 amRNSNotice of Results
6th Jul 20157:00 amRNSAppointment of Chairman
21st May 20154:28 pmRNSManagement Update
21st May 20154:28 pmRNSInterim Management Statement - Q1 2015
19th May 20151:15 pmRNSUnconnected Analyst Presentation
8th May 20152:05 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1st May 20154:00 pmRNSExercise of Over-allotment Option & End of Stabili
27th Apr 20153:26 pmRNSHolding(s) in Company
10th Apr 201510:30 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Apr 20157:00 amRNSAdmission to Trading
1st Apr 20152:09 pmRNSPublication of Prospectus
1st Apr 20157:00 amRNSIPO Pricing Announcement
1st Apr 20157:00 amRNSStabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.